Oct 27 (Reuters) - Vitrolife AB VITR.ST :
* INTERIM REPORT Q3, 2022: ACTIONS DONE AND SYNERGIES AHEAD
* Q3 SALES OF SEK 798 (406) MILLION, CORRESPONDING TO AN
INCREASE
OF 97% IN SEK
* Q3 OPERATING INCOME BEFORE DEPRECIATION AND AMORTISATION
(EBITDA) WAS SEK 276 (162) MILLION
* Q3 NET INCOME WAS SEK 108 (105) MILLION
* ASIA GREW 10%, DESPITE A MAJOR DECREASE IN CHINA RELATED
TO THE
ZERO-COVID POLICY
* EMEA DECLINED 8% AND IS RELATED TO MACRO AND GEOPOLITICAL
UNCERTAINTY, NORMALISATION OF INVENTORY LEVELS AND LOWER SALES
OF TIME-LAPSE
Source text for Eikon: ID:nWkr21MXb2
Further company coverage: VITR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))